InsidersTradesSigma
Follow the 메쥬 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 메쥬 has logged 3 reports. Market capitalisation: €119.7bn. The latest transaction was reported on 1 April 2026 (Purchase). Among the most active insiders: 신재연. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
메쥬 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo y distribución de productos farmacéuticos.